Hormonal management of premenstrual syndrome

Sa'adatu Bose Usman1, Radha Indusekhar1, Shaughn O'Brien1
1Department of Obstetrics and Gynaecology, University Hospital of North Staffordshire, Stoke on Trent ST4 6QG, UK

Tài liệu tham khảo

Panay, 2005, Premenstrual syndrome: making sense of the options, Pulse, 65, 50

Halbreich, 2003, The prevalence, impairment, impact and burden of premenstrual dysphoric disorder (PMS/PMDD), Psychoneuroendocrinology, 28, 1, 10.1016/S0306-4530(03)00098-2

Backstrom, 2003, The role of hormones and hormonal treatments in premenstrual syndrome, CNS Drugs, 17, 325, 10.2165/00023210-200317050-00003

Hussain, 1992, Buserilin in premenstrual syndrome, J Gynaecol Endocrinol, 6, 57, 10.3109/09513599209081007

Hammarback, 1985, Cyclical mood changes as in the premenstrual tension syndrome during sequential estrogen–progestogen postmenopausal replacement treatment, Acta Obstet Gynecol Scand, 64, 393, 10.3109/00016348509155154

Rapkin, 1997, Progesterone metabolite allopregnanolone in women with premenstrual syndrome, Obstet Gynecol, 90, 709, 10.1016/S0029-7844(97)00417-1

Brambilla, 2003, GABAergic dysfunction in mood disorders, Mol Psychiatry, 8, 721, 10.1038/sj.mp.4001362

Bicikova, 1998, Allopregnanolone in women with premenstrual syndrome, Horm Metab Res, 30, 227, 10.1055/s-2007-978871

Genazzani, 2006, Neuroendocrine correlates of premenstrual syndrome, Gynaecol Forum, 11, 23

Beauchamp, 2000, Neurosteroids and reward: allopregnanolone produces a conditioned place aversion in rats, Pharmacol Biochem Behav, 67, 29, 10.1016/S0091-3057(00)00299-9

Backstrom, 2006, Hormones and premenstrual syndrome, Gynaecol Forum, 11, 20

Halbreich, 2006, Diagnosis of premenstrual syndrome, Gynaecol Forum, 11, 5

Ismail, 2006

Ford, 2006, Progesterone for premenstrual syndrome, Cochrane Database Syst Rev, 4, 10.1002/14651858.CD003415.pub2

Magill, 1995, Investigations of the efficacy of progesterone pessaries in the relief of symptoms of premenstrual syndrome, Br J Gen Pract, 45, 589

Veneslow, 1996, Effect of progesterone and its 5 alpha and 5 beta metabolites on symptoms of premenstrual syndrome according to route of administration, J Psychosom Obstet Gynaecol, 17, 29, 10.3109/01674829609025661

Wyatt, 2001, Efficacy of progesterone and progestogens in the management of premenstrual syndrome: systematic review, BMJ, 323, 776, 10.1136/bmj.323.7316.776

Watson, 1989, Treatment of severe premenstrual syndrome with oestradiol patches and cyclical oral norethisterone, Lancet, 2, 730, 10.1016/S0140-6736(89)90784-8

De Ligieres, 1986, Prevention of premenstrual migraine by percutaneous oestradiol, BMJ, 293, 1540, 10.1136/bmj.293.6561.1540

Magos, 1986, Treatment of premenstrual syndrome by subcutaneous oestradiol implants and cyclical oral norethisterone: placebo controlled study, BMJ, 292, 1629, 10.1136/bmj.292.6536.1629

Rapkin, 2003, A review of treatment of premenstrual syndrome and premenstrual dysphoric disorder, Psychoneuroendocrinology, 28, 39, 10.1016/S0306-4530(03)00096-9

Freeman, 2001, Evaluation of a unique oral contraceptive in the treatment of premenstrual dysphoric disorder, J Womens Health Gend Based Med, 10, 561, 10.1089/15246090152543148

Dickerson, 2002, Quality of life issues. Potential role for an oral contraceptive containing ethinyl estradiol and drosperinone, J Reprod Med, 47, 985

Wyatt, 2004, The effectiveness of GnRHa with or without ‘addback’ therapy in treating premenstrual syndrome: a meta analysis, Br J Obstet Gynaecol, 111, 585, 10.1111/j.1471-0528.2004.00135.x

Hahn, 1995, A randomised, placebo-controlled crossover trail of danazol for the treatment of premenstrual syndrome, Psychoneuroendocrinology, 20, 193, 10.1016/0306-4530(94)00053-D

Wetzig, 1994, Mastalgia: a 3-year Australian study, Aust N Z J Surg, 64, 329, 10.1111/j.1445-2197.1994.tb02221.x

O'Brien, 1999, Randomised controlled trial of the management of premenstrual syndrome and premenstrual mastalgia using luteal phase-only danazol, Am J Obstet Gynecol, 180, 18, 10.1016/S0002-9378(99)70142-0

Kaleli, 2001, Symptomatic treatment of premenstrual mastalgia in premenstrual women with lisuride maleate: a double-blind placebo-controlled randomised study, Fertil Steril, 75, 718, 10.1016/S0015-0282(01)01668-5

Benedek-Jaszmann, 1976, Premenstrual tension and functional infertility: aetiology and treatment, Lancet, 1, 1095, 10.1016/S0140-6736(76)90062-3

Graham, 1978, Prolactin suppression in the treatment of premenstrual tension syndrome, Med J Aust, 2, 18, 10.5694/j.1326-5377.1978.tb77381.x

O'Brien, 1979, Treatment of premenstrual syndrome by spironolactone, Br J Obstet Gynaecol, 86, 142, 10.1111/j.1471-0528.1979.tb10582.x

Aslaksen, 1991, Spironolactone in the treatment of premenstrual tension: a double-blind study of spironolactone versus bendroflumethiaxide and placebo, Curr Ther Res, 49, 120

Vellacott, 1987, A double-blind, placebo-controlled evaluation of spironolactone in the premenstrual syndrome, Curr Med Res Opin, 10, 450, 10.1185/03007998709112403

Hellberg, 1991, Premenstrual tension: a placebo-controlled efficacy study with spironolactone and medroxyprogesterone acetate, Int J Gynaecol Obstet, 34, 243, 10.1016/0020-7292(91)90357-B

Wang, 1995, Treatment of premenstrual syndrome by spironolactone: a double-blind, placebo-controlled study, Acta Obstet Gynecol Scand, 74, 803, 10.3109/00016349509021201

Burnet, 1991, Premenstrual syndrome and spironolactone, Aust N Z J Obstet Gynaecol, 31, 366, 10.1111/j.1479-828X.1991.tb02824.x

Dimmock, 2000, Efficacy of selective serotonin re-uptake inhibitors in premenstrual syndrome: a systematic review, Lancet, 356, 1131, 10.1016/S0140-6736(00)02754-9

Cohen, 2002, Premenstrual daily fluoxetine for premenstrual dysphoric disorder: a placebo- controlled, clinical trial using computerized diaries, Obstet Gynecol, 100, 435, 10.1016/S0029-7844(02)02166-X

Halbreich, 2002, Efficacy of intermittent, luteal phase sertraline treatment of premenstrual dysphoric disorder, Obstet Gynecol, 100, 1219, 10.1016/S0029-7844(02)02326-8

Wikander, 1998, Citalopram in premenstrual dysphoria: is intermittent treatment during luteal phase more effective than continuous medication throughout the menstrual cycle?, J Clin Psychopharmacol, 18, 390, 10.1097/00004714-199810000-00007

Pearlstein, 1997, Comparison of fluoxetine, bupropion and placebo in the treatment of premenstrual dysphoric disorder, J Clin Psychopharmacol, 17, 261, 10.1097/00004714-199708000-00004

Freeman, 1999, Differential response to antidepressants in women with premenstrual syndrome/premenstrual dysphoric disorder: a randomised controlled trial, Arch Gen Psychiatry, 56, 932, 10.1001/archpsyc.56.10.932

De Souza, 2000, A synergistic effect of a daily supplement for one month of 200 mg magnesium plus 50 mg Vit B6 for the relief of anxiety related premenstrual symptoms: a randomised, double blind, crossover study, J Women's Health Gend Based Med, 9, 131, 10.1089/152460900318623

Thys-Jacobs, 1998, Calcium carbonate and the premenstrual syndrome: effects on premenstrual and menstrual symptoms. Premenstrual Syndrome Study Group, Am J Obstet Gynecol, 179, 444, 10.1016/S0002-9378(98)70377-1

Schellenberg, 2001, Treatment for the premenstrual syndrome with Agnus castus fruit extract: prospective randomised placebo controlled study, BMJ, 322, 134, 10.1136/bmj.322.7279.134

Bibi, 1995, The effects of aerobic exercise on premenstrual syndrome symptoms, Dissert Abst Int, 56, 6678

Cronje, 2004, Hysterectomy and bilateral oophorectomy for severe premenstrual syndrome, Hum Reprod, 19, 2152, 10.1093/humrep/deh354